Ahles, T. A., A. J. Saykin, et al. (2010). "Longitudinal Assessment of Cognitive Changes Associated With Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve." Journal of Clinical Oncology 28(29): 4434-4440.

Anasti, J. N. (1998). "Premature ovarian failure: an update. [Review] [100 refs]." Fertility & Sterility.70(1):1-15.

Andersen, B. L., B. Anderson, et al. (1989). "Controlled prospective longitudinal study of women with cancer: I. Sexual functioning outcomes." J Consult Clin Psychol 57(6): 683-691.

Anderson, R. A. and D. A. Cameron (2011). "Pretreament Serum Anti-Mullerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer." J Clin Endocrinol Metab: jc.2010-2582.

Andritsch, E., G. Goldzweig, et al. (2004). "Changes in psychological distress of women in long-term remission from breast cancer in two different geographical settings: a randomized study." Support Care Cancer 12(1): 10-18.

Androgen therapy in women guideline taskforce. (2006) Androgen therapy in women: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 91: 3697-3716

Aranda, S., P. Schofield, et al. (2006). "Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial." Br J Cancer 95(6): 667-673.

Atsma F, Bartelink ML et al., (2006) Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 13:265-279.

Avis, N., Crawford S, et al. (2004). "Psychosocial problems among younger women with breast cancer." Psychoncology 13(5): 295-308.

Avis, N. E. (2008). "Breast Cancer Survivors and Hot Flashes: The Search for Nonhormonal Treatments." Journal of Clinical Oncology 26(31): 5008-5010.

Avis, N. E., S. Crawford, et al. (2004). "Psychosocial problems among younger women with breast cancer." Psychooncology 13(5): 295-308.

Bachmann GA, Bancroft J et al., (2001) Female androgen insufficiency: The Princeton consensus statement on definition, classification and assessment Fertil Steril 77: 665-670

Badger, T., C. Segrin, et al. (2007). "Depression and anxiety in women with breast cancer and their partners." Nurs Res 56(1): 44-53.

Barron, T. I., R. Connolly, et al. (2007). "Early discontinuation of tamoxifen: a lesson for oncologists." Cancer 109(5): 832-839.

Barton, D. L., B. I. LaVasseur, et al. (2010). "Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9." Journal of Clinical Oncology 28(20): 3278-3283.

Barton, D. L., D. B. Wender, et al. (2007). "Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3." J Natl Cancer Inst 99(9): 672-679.

Begg S, Vos T, et al. The burden of disease and injury in Australia in 2003. Australian Institute of Health and Welfare. http://www.aihw.gov.au/publications/index.cfm/title/10317

Bellerose, S. and Y. Binik (1993). "Body image and sexuality in opphorectomized women." Arch Sex Behav 22(5): 435-459.

Bernhard, J., D. Zahrieh, et al. (2007). "Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII." J Clin Oncol 25(3): 263-270.

Blumenfeld, Z. (2007). "How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries." The Oncologist 12(9): 1044-1054.

Boekhout, A. H., J. H. Beijnen, et al. (2006). "Symptoms and Treatment in Cancer Therapy-Induced Early Menopause." Oncologist 11(6): 641-654.

Bordeleau, L., K. I. Pritchard, et al. (2010). "Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors." Journal of Clinical Oncology 28(35): 5147-5152.

Bower, J. E. (2008). "Behavioral Symptoms in Patients With Breast Cancer and Survivors." Journal of Clinical Oncology 26(5): 768-777.

Brezden, C. B., K.-A. Phillips, et al. (2000). "Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy." Journal of Clinical Oncology 18(14): 2695-2701.

Burger, H. G., G. E. Hale, et al. (2008). "Cycle and hormone changes during perimenopause: the key role of ovarian function." Menopause 15(4 Pt 1): 603-612.

Burgess, C., V. Cornelius, et al. (2005). "Depression and anxiety in women with early breast cancer: five year observational cohort study." BMJ 330(7493): 702.

Carpenter, J. S., M. A. Andrykowski, et al. (1998). "Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life." Cancer 82(9): 1682-1691.

Cohen, L. S., C. N. Soares, et al. (2006). "Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles." Arch Gen Psychiatry 63(4): 385-390.

Col, N. F., J. R. Guthrie, et al. (2009). "Duration of vasomotor symptoms in middle-aged women: a longitudinal study." Menopause 16(3): 453-457.

Cooke, A. L., C. Metge, et al. (2008). "Tamoxifen Use and Osteoporotic Fracture Risk: A Population-Based Analysis." Journal of Clinical Oncology 26(32): 5227-5232.

Coulam, C. B., S. C. Adamson, et al. (1986). "Incidence of premature ovarian failure." Obstet Gynecol 67(4): 604-606.

Couzi, R., K. Helzlsouer, et al. (1995). "Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy." Journal of Clinical Oncology 13(11): 2737-2744.

Crandall, C., L. Petersen, et al. (2004). "Association of breast cancer and its therapy with menopause-related symptoms." Menopause 11(5): 519-530.

Davis, S. R., M. Moreau, et al. (2008). "Testosterone for low libido in postmenopausal women not taking estrogen." N Engl J Med 359(19): 2005-2017.

Davison, S. L., R. Bell, et al. (2005). "Androgen levels in adult females: changes with age, menopause, and oophorectomy." J Clin Endocrinol Metab 90(7): 3847-3853.

Del Mastro, L., C. T, et al. (2005). "Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients." Annals of Oncology 17: 74-78.

Dennerstein L, Dudley EC et al., (2000) A prospective population-based study of menopausal symptoms Obstet Gynecol 96: 351-358.

Dennerstein, L., J. L. Alexander, et al. (2003). "The menopause and sexual functioning: a review of the population-based studies. [Review] [41 refs]." Annual Review of Sex Research.14:64-82.

Dennerstein L, Lehert P et al., Sexuality. American Journal of Medicine (2005) 118 Suppl 12B:59-63.

Duffy, C., Allen,S., et al. (2005). "Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy." J Clin Oncol 23(4): 766-773.

Duffy, L., D. Greenberg, et al. (1999). "Iatrogenic acute estrogen deificiency and psychiatric syndromes in breast cancer patients." Psychosomatics 40(4): 304-308.

Eastell, R., J. E. Adams, et al. (2008). "Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230." Journal of Clinical Oncology 26(7): 1051-1057.

Eisen, A., M. Trudeau, et al. (2008). "Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review." Cancer Treat Rev 34(2): 157-174.

The ESRE Capri Workshop. (2006). "Hormones and cardiovascular health in women." Hum Reprod Update 12(5): 483-497.

Faddy, M. J., R. G. Gosden, et al. (1992). "Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause." Hum Reprod 7(10): 1342-1346.

Fallowfield, L. (1997). "Offering choice of surgical treatment to women with breast cancer." Patient Educ Couns 30(3): 209-214.

Fallowfield, L., D. Cella, et al. (2004). "Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial." Journal of Clinical Oncology 22(21): 4261-4271.

Farquar,C., Marjoribanks, J., et al. (2009)Long term hormone therapy for perimenopausal and postmenopausal women [Systematic Review]." Cochrane Database of Systematic Reviews 11: 11.

Fobair, P., S. L. Stewart, et al. (2006). "Body image and sexual problems in young women with breast cancer." Psychooncology 15(7): 579-594.

Freedman, R. R. (2005). "Pathophysiology and treatment of menopausal hot flashes." Seminars in Reproductive Medicine 23(2): 117-125.

Gallagher JC. (2007) Effect of early menopause on bone mineral density and fractures. Menopause 14: 567-571.

Ganz, P. A., J. H. Rowland, et al. (1998). "Life after breast cancer: understanding women's health-related quality of life and sexual functioning." J Clin Oncol 16(2): 501-514.

Ganz, P. A., G. A. Greendale, et al. (2000). "Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial." J Natl Cancer Inst 92(13): 1054-1064.

Ganz, P. A., K. A. Desmond, et al. (2002). "Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study." J Natl Cancer Inst 94(1): 39-49.

Ganz, P., G. Greendale, et al. (2003). "Breast cancer in younger women: reproductive and late health effects of treatment." Journal of Clinical Oncology 21(22): 4184-4193.

Ganz, P. A., L. Kwan, et al. (2011). "Physical and Psychosocial Recovery in the Year After Primary Treatment of Breast Cancer." Journal of Clinical Oncology 29(9): 1101-1109.

Geller, S. E., L. P. Shulman, et al. (2009). "Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial." Menopause 16(6): 1156-1166.

Gerber, B., M. Dieterich, et al. (2008). "Controversies in preservation of ovary function and fertility in patients with breast cancer." Breast Cancer Res Treat 108(1): 1-7.

Goodwin, P. J. (2009). "Vitamin D in cancer patients: above all do no harm." Journal of Clinical Oncology, 27(13): 2117-2119.

Greenfield, S., S. Kaplan, et al. (1985). "Expanding patient involvement in care. Effects on patient outcomes." Ann Intern Med 102(4): 520-528.

Greenfield, S., S. H. Kaplan, et al. (1988). "Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes." J Gen Intern Med 3(5): 448-457.

Gupta, P., D. W. Sturdee, et al. (2006). "Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life." Climacteric 9(1): 49-58.

Hackshaw, A., M. Roughton, et al. (2011). "Long-Term Benefits of 5 Years of Tamoxifen: 10-Year Follow-Up of a Large Randomized Trial in Women at Least 50 Years of Age With Early Breast Cancer." Journal of Clinical Oncology 29(13): 1657-1663.

Hadji, P. (2010). "Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy." Critical Reviews in Oncology-Hematology 73(2): 156-166.

Haynes, R. B., K. A. McKibbon, et al. (1996). "Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications." Lancet 348(9024): 383-386.

Henderson VW and Sherwin BB. (2007) Surgical versus natural menopause: cognitive issues. Menopause 14; 572-579.

Henderson, V. W. (2008). "Cognitive changes after menopause: influence of estrogen. [Review] [45 refs]." Clinical Obstetrics & Gynecology 51(3): 618-626.

Herman, D. R., P. A. Ganz, et al. (2005). "Obesity and cardiovascular risk factors in younger breast cancer survivors: The Cancer and Menopause Study (CAMS)." Breast Cancer Res Treat 93(1): 13-23.

Hickey, M., M. Peate, et al. (2009). "Breast cancer in young women and its impact on reproductive function." Human Reproduction Update 15(3): 323-339.

Hickey, M., C. Saunders, et al. (2008). "Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. [Review] [124 refs]." Annals of Oncology 19(10): 1669-1680.

Hines, S. L., H. K. S. Jorn, et al. (2010). "Breast cancer survivors and vitamin D: a review." Nutrition 26(3): 255-262.

Holmberg, L. and H. Anderson (2004). "HABITS (hormonal replacement therapy after breast cancer--is it safe?), a randomised comparison: trial stopped." Lancet 363(9407): 453-455.

Hunter, M. S. (1992). "The South East England longitudinal study of the Climacteric and postmenopause." Marituritas 14: 117-126.

Innesa, K. E., T. K. Selfea, et al. (2010). "Mind-body therapies for menopausal symptoms: A systematic review" Maturitas 66: 135-149.

Jones, L. W., M. Haykowsky, et al. (2007). "Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer." Oncologist 12(10): 1156-1164

Jones G, Nguyen P et al., (1994) Symptomatic fracture Incidence in Elderly men and women: The Dubbo Osteoporosis Epidemiology Study (DOES). Osetoporosis Int 4:277-282.

Kalantaridou, S. N., K. K. Naka, et al. (2006). "Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement." Trends Endocrinol Metab 17(3): 101-109.

Kalantaridou, S. N., K. K. Naka, et al. (2004). "Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy." Journal of Clinical Endocrinology & Metabolism.89(8):3907-13.

Kelly, C. M., D. N. Juurlink, et al. (2010). "Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study." BMJ 340: c693.

Kenemans, P., N. J. Bundred, et al. (2009). "Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial." Lancet Oncol 10(2): 135-146.

Kissane, D. W., B. Grabsch, et al. (2004). "Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis." Aust N Z J Psychiatry 38(5): 320-326.

Knobf, M. T. (1998). "Natural menopause and ovarian toxicity associated with breast cancer therapy." Oncol Nurs Forum 25(9): 1519-1530; quiz 1531-1512.

Knobf, M. T. (2006). "Reproductive and hormonal sequelae of chemotherapy in women." Cancer Nurs 29(2 Suppl): 60-65.

Knobf, M. T. (2006). "Reproductive and hormonal sequelae of chemotherapy in women." Cancer Nurs 29(2 Suppl): 60-65.

Lisabeth LD, Beiser AS et al., (2009) Age at natural menopause and risk of ischaemic stroke: The Framingham Heart study. Stroke 40:1044-1049.

Lobo RA (2007) Surgical Menopause and cardiovascular risks. Menopause 14: 562-566.

Loprinzi, C. L., J. Sloan, et al. (2009). "Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis." Journal of Clinical Oncology 27(17): 2831-2837.

MacLennan AH. (2009). "Evidence based review of therapies at the menopause." Int J Evid Based Healthc 7: 11.

Maki, P. M. and E. Sundermann (2009). "Hormone therapy and cognitive function." Human Reproduction Update: dmp022.

Mantani, T., T. Saeki, et al. (2007). "Factors related to anxiety and depression in women with breast cancer and their husbands: role of alexithymia and family functioning." Support Care Cancer 15(7): 859-868.

McKinlay, S. M., D. J. Brambilla, et al. (1992). "The normal menopause transition." Maturitas 14(2): 103-115.

Mondul AM, Rodriguez C et al., (2005) Age at natural menopause and cause-specific mortality. Am J Epidemiol 162:1089-1097.

Mouridsen, H., A. Keshaviah, et al. (2007). "Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial." J Clin Oncol 25(36): 5715-5722.

Nedrow, A., J. Miller, et al. (2006). "Complementary and Alternative Therapies for the Management of Menopause-Related Symptoms: A Systematic Evidence Review." Arch Intern Med 166: 1453-1465.

Nelson, H. D., K. K. Vesco, et al. (2006). "Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis." JAMA 295(17): 2057-2071.

Nelson, L. M. (2009). "Primary ovarian insufficiency." New England Journal of Medicine. 360: 606-614.

Nichols, H. B., et al., (2009). " Body Mass Index Before and After Breast Cancer Diagnosis: Associations with All-Cause, Breast Cancer, and Cardiovascular Disease Mortality. ." Cancer Epidemiology Biomarkers & Prevention 18(5): 1403-1409.

Nippita TA , B. R. (2007). "Premature ovarian failure: a review." Climacteric 10: 11.

Ortmann, O., O. Pagani, et al. (2011). "Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel." Cancer Treatment Reviews 37(2): 97-104.

Ossewarde ME, Bots ML et al., Age at menopause, cause specific mortality and total life expectancy. Epidemiology (2005) 16: 556-562.

Panjari, M., R. J. Bell, et al. (2011). "Sexual function after breast cancer." J Sex Med 8(1): 294-302

Parker WH, Broder MS et al., (2009) Ovarian conservation at the time of hysterectomy and long term health outcomes in the Nurse's Health Study. Obstet Gynecol 113:1027-1037.

Pasquali, E. A. (2002). "Premature menopause and self-concept disjunctions. A case for crisis management." J Psychosoc Nurs Ment Health Serv 40(9): 20-29.

Payne, D. K., R. G. Hoffman, et al. (1999). "Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care." Psychosomatics 40(1): 64-69.

Pektek JA, Naughton. M. J. et al. (2006). "Incidence, time course and determinants of menstrual bleeding after breast cancer treatment: a prospective study." Journal of Clinical Oncology 24: 1045-1051.

Phillips, K.-A., J. Aldridge, et al. (2011). "Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial." Breast Cancer Research and Treatment 126(1): 221-226.

Politi, M. C., M. D. Schleinitz, et al. (2008). "Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis." J Gen Intern Med 23(9): 1507-1513.

Rivera CM, Grossardt BR et al., (2009) Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 16:15-23.

Rivera-Woll Lm, Papalia M, et al., (2004) Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 10:421-432.

Roberts, H. (2010). "Safety of herbal medicinal products in women with breast cancer" Maturitas 66: 363-369.

Rocca WA, Grosshardt BR et al., (2006) Survival patterns after oophorectomy in premenopausal women: a population based study. Lancet Oncol 7:821-828.

Rocca WA, Bower JH et al., (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69: 1074-1083.

Rostom, A. Y. (2001). "The management of menopausal sequelae in patients with breast cancer." Clin Oncol (R Coll Radiol) 13(3): 174-180.

Santen, R. J., D. C. Allred, et al. (2010). "Postmenopausal hormone therapy: an Endocrine Society scientific statement." J Clin Endocrinol Metab 95(7 Suppl 1): s1-s66.

Sayakhot, P., A. Deeks, et al. (2011). "Potential adverse impact of ovariectomy on physical and psychological function of younger women with breast cancer." Menopause 18(7).

Schag CA, Ganz PA, et al. (1993). "Characteristics of women at risk for psychosocial distress in the year after breast cancer." J of Clinical oncology 11(4): 783-793.

Schilder, C. M., C. Seynaeve, et al. (2010). "Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial." Journal of Clinical Oncology 28(8): 1294-1300.

Schover, L. (1994). "Sexuality and body image in younger women with breast cancer." J Natl Cancer Inst 16: 177-182.

Schover, L. R. (2008). "Premature Ovarian Failure and Its Consequences: Vasomotor Symptoms, Sexuality, and Fertility." Journal of Clinical Oncology 26(5): 753-758.

Schover, L. R. (2008). "Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility." J Clin Oncol 26(5): 753-758.

Shapiro, S. L., A. M. Lopez, et al. (2001). "Quality of life and breast cancer: relationship to psychosocial variables." J Clin Psychol 57(4): 501-519.

Somboonporn W, Bell RJ, Davis SR. (2005) Testosterone for peri and postmenopausal women. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004509. DOI:10.1002/14651858.CD004509.pub2.

Soules MR , Sherman S et al., (2001) Executive summary: Stages of reproductive aging workshop (STRAW). Fertil Steril. 76:874-878

Stewart A, Bielajew C, et al. (2006). " A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer." Clin Neuropsychol 20: 76-89.

Stearns, V., B. Schneider, et al. (2006). "Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants." Nature Reviews Cancer 6(11): 886-893.

Street, R. L., Jr. and B. Voigt (1997). "Patient participation in deciding breast cancer treatment and subsequent quality of life." Med Decis Making 17(3): 298-306.

Suckling JA., Kennedy R, et al. (2010). "Local oestrogen for vaginal atrophy in postmenopausal women [Systematic Review]

Sukumvanich, P., L. D. Case, et al. (2010). "Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study." Cancer 116(13): 3102-3111.

Taylor, A. E. (2001). "Should women with premature menopause be screened for FMR-1 mutations?" Menopause 8(2): 81-83.

Thewes, B., B. Meiser, et al. (2005). "Fertility - and menopause-related information needs of younger women with a diagnosis of early breast cancer." J Clin Oncol 23(22).

Trinkaus, M., Chin S, et al. (2008). "Should Urogenital Atrophy in Breast Cancer Survivors Be Treated with Topical Estrogens?." The Oncologist 13: 222-231.

Tuppurainen M, Kroger H et al., (2005) Risks of perimenopausal fractures- a prospective population based study. Acta Obstet Gynecol Scand 74: 624-628

Van der Klift M, deLaet CE, et al., Risk factors for incident vertebral fractures in men and women: the Rotterdam study. J Bone Miner Res (2005) 20: 1172-1180.

Vance, V. e. a. (2010). "Weight gain in breast cancer survivors: prevalence, pattern and health consequences. ." Obesity Reviews: 1-13.

Walshe, J. M., N. Denduluri, et al. (2006). "Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer." J Clin Oncol 24(36): 5769-5779.

Weiss, S. M., P. A. Wengert, Jr., et al. (1996). "Patient satisfaction with decision-making for breast cancer therapy." Ann Surg Oncol 3(3): 285-289.

Writing Group of the W. H. O. (1996). "Research on the menopause in the 1990's. ." World Health Organisation 866: 1-79.

Young-McCaughan, S. (1996). "Sexual functioning in women with breast cancer after treatment with adjuvant therapy." Cancer Nurs 19(4): 308-319.

Content updated May 16, 2011